AMAL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMAL is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has an overall constructive technical setup, but the current setup lacks a clear high-conviction catalyst, analysts remain mixed-to-neutral, insiders are selling, and there is no strong proprietary buy signal. I would not call it a clear buy today; hold or wait for a better entry is the better call.
AMAL's trend is moderately bullish. The SMA_5 is above SMA_20 and SMA_200, which supports a longer-term uptrend. MACD histogram is positive at 0.137, though it is contracting, suggesting upside momentum is weakening somewhat. RSI_6 at 55.529 is neutral-to-slightly bullish, not overbought. Price at 46.03 is just above the pivot level of 45.675 and below resistance at R1 47.394, so the stock is trading in a relatively tight zone with near-term upside limited unless it breaks resistance. The short-term pattern data also suggests mixed near-term performance, with downside probabilities still meaningful.
["SMA_5 > SMA_20 > SMA_200 indicates a bullish trend structure", "MACD histogram remains positive", "Piper Sandler raised the price target to $48 from $44", "Q1 revenue grew 9.7% year over year to $93.4 million", "Stock is up 49% over the past year"]
["Insiders are selling, and selling increased 421.50% over the last month", "Analyst stance is mostly Neutral despite recent target increases", "Options open interest put-call ratio of 1.87 suggests cautious sentiment", "No AI Stock Picker signal today", "No SwingMax signal recently", "No recent congress trading data", "Technical momentum is positive but contracting", "Near-term pattern data shows meaningful chance of short-term downside"]
Latest quarter shown is Q1. Revenue increased 9.7% year over year to $93.4 million, which is a healthy growth rate for a financial company. The news also noted better deposit growth and improved PPNR results, suggesting operational improvement. However, the available data does not include full earnings, margins, or EPS details, so the growth picture is positive but incomplete.
Analyst sentiment is mixed but constructive. Piper Sandler raised its price target to $48 from $44 and kept a Neutral rating, while Keefe Bruyette raised its target to $48 from $43 and maintained an Outperform rating. Overall, Wall Street sees some upside and better fundamentals, but the dominant message is still cautious rather than strongly bullish.
